Birko’s Beefxide® Effective Against Non-O157 STECs
HENDERSON, Colo. – Recent research has demonstrated that lactic acid-based antimicrobials, such as Birko’s Beefxide®, are effective in reducing non-O157 Shiga toxin-producing E. coli (STEC) in beef trimmings.
“We have demonstrated that Beefxide® is highly effective against E. coli O157:H7, and this research supports our expectation that it will be effective against the non-O157 STECs as well,” said Dr. Elis Owens, a chemist/microbiologist at Birko. Beefxide® is also effective in reducing Salmonella, Campylobacter and Listeria. The research was conducted by Colorado State University and funded by the American Meat Institute Foundation.
Beefxide® has been approved by the USDA for use as an antimicrobial processing aid on beef intended for human consumption. Beefxide® is formulated from FDA-approved ingredients and all components of the formula are GRAS. Beefxide® is also suitable for use on products to be labeled as natural or organic.
Birko is a leading provider of food safety solutions to the protein processing, food and beverage industries. Birko manufactures concentrated CIP, sanitation, antimicrobial intervention and process chemical formulations. Birko’s equipment division designs and manufactures chemical dispensing systems, antimicrobial mixing and spraying conveyors and carcass washing and pasteurizing equipment. Birko’s information technology includes BirkoStats™, an online chemical usage tracking system, and VerifEYE™, a fecal identification imaging system. Founded in 1953, Birko is a WBENC Certified Women’s Business Enterprise and was awarded Supplier of the Century by the National Meat Association. birkocorp.com